19
Jan
2009
Posted in I - Series D, Q - 1Q09, R - WEST, X - Device (ENT), XX - CA
Acclarent (Menlo Park, CA) focused on improving patient care in all areas of otolaryngology by developing and producing medical devices solely for ear, nose and throat, closed a $26M Series D financing. Participants include Johnson & Johnson Development Corp., New Enterprise Associates, Delphi Ventures, Versant Ventures and Meritech Capital Partners.
30
Nov
2008
30
Nov
2008